Evidence map›Paper›PMID 39412159›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver-Russell Syndrome and Focus on the IGF1R Gene.

Alessandro Vimercati, Pierpaola Tannorella, Sara Guzzetti, Luciano Calzari, Davide Gentilini, Emanuela Manfredini, Giulia Gori, Rossella Gaudino, Vincenzo Antona, Maria Piccione and 14 more

Erratum issuedAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Alessandro VimercatiResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Pierpaola TannorellaResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Sara GuzzettiResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Luciano CalzariBioinformatics and Statistical Genomic Unit, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Davide GentiliniBioinformatics and Statistical Genomic Unit, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Emanuela ManfrediniResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Giulia GoriMedical Genetics Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.
Rossella GaudinoPediatric Unit, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, 37129 Verona, Italy.
Vincenzo AntonaDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro," University of Palermo, 90127 Palermo, Italy.
Maria PiccioneMedical Genetics Unit Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Cecilia DaolioDepartment of Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Renata AuricchioEuropean Laboratory for the Investigation of Food Induced Diseases, Department of Translational Medical Science, Section of Pediatrics, University Federico II, 80131 Naples, Italy.
Fabio SirchiaMedical Genetic Unit, Department of Diagnostic Medicine, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy.
Antonella MinelliMedical Genetic Unit, Department of Diagnostic Medicine, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy.
Elena RossiDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Melissa BelliniPediatrics and Neonatology Unit, Gugliemo da Saliceto Hospital, 29121 Piacenza, Italy.
Giacomo BiasucciPediatrics and Neonatology Unit, Gugliemo da Saliceto Hospital, 29121 Piacenza, Italy.
Annalisa Russo RaucciDivision of Genetics and Cell Biology and Laboratory of Clinical Molecular Biology and Cytogenetics, Unit of Genomics for Human Disease Diagnosis, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Gabriella PozzobonPediatric Endocrinology Unit, San Raffaele Hospital, 20132 Milan, Italy.
Giuseppa PattiPaediatric Endocrinology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Flavia NapoliPaediatric Endocrinology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0003-3567-6118
Lidia LarizzaResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
Mohamad MaghniePaediatric Endocrinology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-7183-5238
Silvia RussoResearch Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.ORCID 0000-0002-5893-0193

Funding

BIBLIOSAN
6 · The paper itself

Abstract

contextSilver-Russell Syndrome (SRS) is a growth retardation disorder characterized by pre- and postnatal growth failure, relative macrocephaly at birth, prominent forehead, body asymmetry, and feeding difficulties. The main molecular mechanisms are imprinting alterations at multiple loci, though a small number of pathogenic variants have been reported in the SRS genes IGF2-PLAG1-HMGA2 and CDKN1C. However, around 40% of clinically suspected SRS cases do not achieve a molecular diagnosis, highlighting the necessity to uncover the underlying mechanism in unsolved cases.

objectiveEvaluate the frequency of genetic variants in undiagnosed SRS patients [Netchine-Harbison Clinical Scoring System (NH-CSS) ≥ 4], and investigate whether (epi)genetic patients may be distinguished from genetic patients.

methodsOne hundred thirty-two clinically SRS patients without (epi)genetic deregulations were investigated by whole-exome (n = 15) and targeted (n = 117) Sequencing. Clinical data from our cohort and from an extensive revision of the literature were compared.

resultsPathogenic variants were identified in 9.1% of this cohort: 3% in IGF2, PLAG1, and HMGA2 genes and 3% in the IGF1R gene, associated with IGF-1 resistance (IGF1RES), an SRS differential diagnosis. Overall, IGF2-PLAG1-HMGA2 and IGF1R account for 3.6% of SRS with NH-CSS score ≥ 4. A clinical cross-comparison of (epi)genetic vs genetic SRS underlined (epi)genotype-phenotype correlation highlighted the prevalence of body asymmetry and relative macrocephaly in mosaic (epi)genetic SRS and recurrence of genetic familial cases. Furthermore, overlapping features were evidenced in (epi)genetic SRS and IGF1RES patients.

conclusionOur study explores the frequency of genetic SRS, underscores body asymmetry as a distinctive phenotype in (epi)genetic SRS and suggests IGF1R sequencing in a SRS diagnostic flowchart.

Indexed as

MutationReceptor, IGF Type 1Receptors, SomatomedinSilver-Russell SyndromeAdolescentChildChild, PreschoolDNA-Binding ProteinsFemaleGenomic ImprintingHMGA2 ProteinHumansInfantInsulin-Like Growth Factor IIMaleDNA-Binding ProteinsHMGA2 ProteinHMGA2 protein, humanIGF1R protein, humanIGF2 protein, humanInsulin-Like Growth Factor IIPLAG1 protein, humanReceptor, IGF Type 1Receptors, Somatomedinbody asymmetry(epi)genetic phenotypefamilial casesIGF1RIGF2-PLAG1-HMGA2 axisSilver–Russell syndrome

Identifiers

PMID39412159
PMCPMC11913091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.